See more : essensys plc (ESYS.L) Income Statement Analysis – Financial Results
Complete financial analysis of Biocure Technology Inc. (CURE.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biocure Technology Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Aareal Bank AG (AAALF) Income Statement Analysis – Financial Results
- Doosan Corporation (000150.KS) Income Statement Analysis – Financial Results
- Numinus Wellness Inc. (NUMI.TO) Income Statement Analysis – Financial Results
- TIS Inc. (3626.T) Income Statement Analysis – Financial Results
- PPC Ltd (PPCLY) Income Statement Analysis – Financial Results
Biocure Technology Inc. (CURE.CN)
About Biocure Technology Inc.
Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and hair growth products. The company was founded in 2005 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.72K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 54.90K | 44.82K | 1.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | -54.90K | -44.82K | -1.06K | 0.00 | 5.72K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 1.48M | 1.56M | 1.42M | 1.36M | 301.45K | 317.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 301.01K | 673.72K | 2.34M | 1.48M | 3.14M | 5.04M | 1.08M | 651.20K | 0.00 | 84.57K | 125.75K | 0.00 | 0.00 | 89.32K | 45.16K | 0.00 |
| Selling & Marketing | 751.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.08M | 673.72K | 2.34M | 1.48M | 3.14M | 5.04M | 1.08M | 651.20K | 82.32K | 84.57K | 125.75K | 107.02K | 148.64K | 89.32K | 45.16K | 6.02K |
| Other Expenses | 0.00 | 17.52K | 76.88K | -71.12K | 44.82K | -2.94K | -3.36M | -1.03M | 0.00 | 0.00 | 0.00 | 0.00 | 1.03K | 0.00 | -25.00K | 0.00 |
| Operating Expenses | 1.08M | 691.24K | 3.90M | 2.97M | 4.60M | 6.45M | 1.41M | 980.51K | 82.32K | 84.57K | 125.75K | 107.02K | 149.67K | 89.32K | 45.16K | 6.02K |
| Cost & Expenses | 1.08M | 691.24K | 3.90M | 2.97M | 4.60M | 6.45M | 1.41M | 980.51K | 82.32K | 84.57K | 125.75K | 107.02K | 149.67K | 89.32K | 45.16K | 6.02K |
| Interest Income | 0.00 | 0.00 | 88.04K | 2.89K | 1.16K | 5.85K | 16.43K | 10.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.43K | 3.79K | 45.00 |
| Interest Expense | 0.00 | 4.99K | 498.89K | 240.12K | 136.93K | 37.97K | 28.46K | 30.89K | 1.22K | 1.19K | 5.69K | 0.00 | 0.00 | 2.43K | 3.79K | 0.00 |
| Depreciation & Amortization | 167.90K | -292.83K | 76.88K | 54.90K | 44.82K | 51.89K | 28.19K | 11.71K | -164.64K | -169.15K | -251.49K | 0.00 | 0.00 | 0.00 | 0.00 | -12.03K |
| EBITDA | -1.08M | -691.24K | -261.98K | -2.91M | -4.55M | -6.40M | -4.72M | -1.98M | -82.32K | -84.57K | -125.75K | -107.02K | -149.67K | -89.32K | -45.16K | -6.02K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -34,622.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.08M | -398.41K | -338.86K | -2.96M | -4.59M | -6.45M | -4.75M | -1.99M | 82.32K | 84.57K | 125.75K | -107.02K | -149.67K | -89.32K | -45.16K | 6.02K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -34,827.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -238.91K | 270.32K | 587.02K | -11.68K | -196.26K | -135.42K | -3.37M | -1.04M | -165.86K | -47.83K | -157.18K | 0.00 | 0.00 | 0.00 | -25.00K | 0.00 |
| Income Before Tax | -1.32M | -403.40K | -1.15M | -3.08M | -4.79M | -6.59M | -4.78M | -2.02M | -83.54K | 36.74K | -31.43K | 0.00 | 0.00 | 0.00 | -70.16K | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -35,299.35% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -442.11 | 753.82K | 3.95M | 107.33K | 86.07K | 97.46K | -2.84K | -3.93K | 164.64K | 46.65K | 151.49K | 107.02K | 149.67K | -4.86K | 17.41K | 11.99K |
| Net Income | -1.81M | -1.16M | -5.10M | -3.19M | -4.88M | -6.59M | -4.78M | -2.02M | -83.54K | 36.74K | -31.43K | -107.02K | -149.67K | -86.89K | -66.37K | -5.97K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -35,299.35% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.02 | -0.01 | -0.05 | -0.03 | -0.05 | -0.07 | -0.05 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.04 | -0.07 | 0.00 |
| EPS Diluted | -0.02 | -0.01 | -0.05 | -0.03 | -0.05 | -0.07 | -0.05 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.04 | -0.07 | 0.00 |
| Weighted Avg Shares Out | 92.86M | 106.92M | 103.04M | 98.15M | 96.94M | 95.79M | 93.39M | 43.34M | 39.13M | 34.07M | 32.62M | 29.30M | 22.52M | 2.00M | 904.11K | 2.00M |
| Weighted Avg Shares Out (Dil) | 92.86M | 106.92M | 103.04M | 98.15M | 96.94M | 95.79M | 93.39M | 43.34M | 39.13M | 34.07M | 32.62M | 29.30M | 22.52M | 2.00M | 904.11K | 2.00M |
Source: https://incomestatements.info
Category: Stock Reports